New solutions for peritoneal dialysis in adult and pediatric patients

Peritoneal Dialysis International

Volumn 19, Issue SUPPL. 2, 1999, Pages

  Shockley, Ty R ^a   Martis, Leo ^a   Tranæus, Anders P ^b  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b Baxter R and D Europe   (Belgium)

Author keywords

Amino acids; Bicarbonate; Glucose polymer; Icodextrin; Peritoneal dialysis solutions

Indexed keywords

AMINO ACID; BICARBONATE; DIALYSIS FLUID; GLUCOSE; GLUCOSE POLYMER; ICODEXTRIN; OSMOTIC AGENT;

BIOCOMPATIBILITY; CALORIC INTAKE; CONFERENCE PAPER; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY FAILURE; MOLECULAR WEIGHT; NAUSEA; NUTRITIONAL VALUE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; ULTRAFILTRATION; VOMITING;

ADULT; AMINO ACIDS; BICARBONATES; CHILD; DIALYSIS SOLUTIONS; GLUCANS; GLUCOSE; HUMANS; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;

EID: 0033374925     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (53)

1. Fenton SS, Johnston N, Delmore T, Detsky AS, Whitewell J, O'Sullivan R, et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients. ASAIO Trans. 1987; 33:650-3.
2. Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scalamogna A, et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study. Am J Kidney Dis. 1991; 17:462-71.
3. Marckmann P. Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin Nephrol. 1988; 29:75-8.
4. Salusky IB, Fine RN, Nelson P, Blumenkrantz MJ, Kopple JD. Nutritional status of children undergoing continuous ambulatory peritoneal dialysis. Am J Clin Nutr. 1983; 38:599-611.
5. Pollock CA, Allen BJ, Warden RA, Caterson RJ, Blagojevic N, Cocksedge B, et al. Total-body nitrogen by neutron activation in maintenance dialysis [Published erratum appears in: Am J Kidney Dis. 1993; 2:237]. Am J Kidney Dis. 1990; 16:38-45.
6. Lindholm B, Bergström J. Nutritional requirements of peritoneal dialysis patients. In: Gokal R, Nolph KD, eds. The Textbook of Peritoneal Dialysis. Dordrecht: Kluwer Academic Publishers; 1994:443-72.
7. Kopple K, Bernard D, Messana J, Swartz R, Bergström J, Lindholm B, et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int. 1995; 47:1148-57.
8. Jones MR, Gehr TW, Burkart JM, Hamburger RJ, Kraus AP Jr, Piraino BM, et al. Replacement of amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution. Perit Dial Int. 1998; 18:210-16.
9. Young GA, Dibble JB, Taylor AE, Kendall S, Brownjohn A. A longitudinal study of the effects of amino acid-based CAPD fluid on amino acid retention and protein losses. Nephrol Dial Transplant. 1989; 4:900-5.
10. Bruno M, Bagnis C, Marangella M, Rovera L, Cantaluppi A, Linari F. CAPD with an amino acid dialysis solution: A long-term, cross-over study. Kidney Int. 1989; 35:1189-94.
11. Arfeen S, Goodship TH, Kirkwood A, Ward MK. The nutritional, metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution. Clin Nephrol. 1990; 33:192-9.
12. Faller B, Aparicio M, Faict D, DeVos C, de Precigout V, Larroumet N, et al. Clinical evaluation of an optimized 1.1% amino-acid solution for peritoneal dialysis. Nephrol Dial Transplant. 1995; 10:1432-7.
13. Oren A, Wu G, Anderson GH, Marliss E, Khanna R, Petitt J, et al. Effective use of amino acid dialysate over four weeks in CAPD patients. ASAIO Trans. 1983; 29:604-10.
14. Pedersen FB, Dragsholt C, Laier E, Frifelt J, Trostmann A, Ekelund S, et al. Alternate use of amino acid and glucose solutions in CAPD. Perit Dial Bull. 1985; 5:215-18.
15. Renzo S, Beatrice D, Giuseppe I. CAPD in diabetics: Use of amino acids. In: Khanna R., Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in Peritoneal Dialysis. Toronto: Peritoneal Dialysis Bulletin, 1990; 6:53-5.
16. Rubin J, Garner T. Positive nitrogen balance after intraperitoneal administration of amino acids in 3 patients. Perit Dial Int. 1994; 14:223-6.
17. Jones M, Hagen T, Algrim-Boyle C, Vonesh E, Hamburger C, Charytan S, et al. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: Results of a multicenter outpatient study. Am J Kidney Dis. 1998; 32:761-9.
18. Dombros N, Prutis K, Tong M, Anderson GH, Harrison J, Sombolos K, et al. Six-month overnight intraperitoneal amino acid infusion on continuous ambulatory peritoneal dialysis (CAPD) patients - No effect on nutritional status. Perit Dial Int. 1990; 10:79-84.
19. Jones MR, Martis L, Algrim CE, Bernard D, Swartz R, Messana J, et al. Amino acid solutions for CAPD: Rationale and clinical experience. Miner Electrolyte Metab. 1992; 18:309-15.
20. Alexander S, Salusky I, Warady B, Watkins S. Peritoneal dialysis modalities - Peritoneal dialysis workshop: Pediatrics recommendations. Perit Dial Int. 1997; 17(Suppl 3):S25-7.
21. Qamar I, Levin L, Balfe W, Balfe J, Secker D, Zlotkin S. Effects of 3-month amino acid dialysis compared to dextrose dialysis in children on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1994; 14:34-41.
22. Hanning R, Balfe J, Zlotkin S. Effectiveness and nutritional consequences of amino acid-based vs. glucose-based dialysis solutions in infants and children receiving CAPD. Am J Clin Nutr. 1987; 46:22-30.
23. Canepa A, Perfumo F, Carrea A, Piccardo M, Ciardi M, Cantaluppi A, et al. Continuous ambulatory peritoneal dialysis (CAPD) of children with amino acid solutions: Technical and metabolic aspects. Perit Dial Int. 1990; 10:215-20.
24. Honda M, Kamiyama Y, Hasegawa O, Hoshinaga K, Ogawa O, Kawamura T, et al. Effect of short-term essential amino acid-containing dialysate in young children on CAPD. Perit Dial Int. 1991; 11:76-80.
25. Canepa A, Perfumo F, Carrea A, Venina S, Menoni S, Trivelli A, et al. Long-term effects of amino acid (AA) solutions in children on automated peritoneal dialysis (APD) [Abstract]. J Am Soc Nephrol. 1996; 7:1441.
26. Rubin J, Klein E, Jones Q, Planch A, Bower J. Evaluation of a polymer dialysate. ASAIO Trans. 1983; 29: 62-6.
27. Winchester JF, Stegink LD, Ahmad S, Gross M, Hammeke M, Horowitz JF, et al. A comparison of glucose polymer and dextrose as osmotic agents in CAPD. In: Maher JF, Winchester JF, eds. Frontiers in Peritoneal Dialysis. New York: Field, Rich and Associates, Inc.; 1986:231-40.
28. Alsop RM. History, chemical, and pharmaceutical development of icodextrin. Perit Dial Int. 1994; 14(Suppl 2):S5-12.
29. Mistry C, Gokal R, Peers E. A randomized multicenter clinical trial comparing isoosmolar icodextrin with hyperosmolar glucose solution in CAPD. Kidney Int. 1994; 46:496-503.
30. Posthuma N, ter Wee PM, Verbrugh HA, Oe PL, Peers E, Sayers J, et al. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. Nephrol Dial Transplant. 1997; 12:550-3.
31. Cooper A, Henderson IS, Jones MC. Daytime dwell with 7.5% icodextrin in automated peritoneal dialysis (APD) [Abstract]. Perit Dial Int. 1995; 15(Suppl 1):S21.
32. Krediet RT, Douma CE, Ho-dac-Pannekeet MM, Imholz AL, Zemel D, Zweers MM, et al. Impact of different dialysis solutions on solute and water transport. Perit Dial Int. 1997; 17(Suppl 2):S17-26.
33. Ho-dac-Pannekeet MM, Schouten N, Langendijk MJ, Hiralall JK, de Waart DR, Struijk DG, et al. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int. 1996; 50:979-86.
34. Krediet RT, Brown CB, Imholz ALT, Koomen, G. Protein clearance and icodextrin. Perit Dial Int. 1994; 14(Suppl 2):S39-44.
35. Wilkie ME, Brown CB. Polyglucose solutions in CAPD. Perit Dial Int. 1997; 17(Suppl 2):S47-50.
36. Gokal R, Mistry CD, Peers EM, and the MIDAS (Multicenter Investigation of Icodextrin in Ambulatory Dialysis) Study Group. Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. Perit Dial Int. 1995; 15:226-30.
37. Davies DD. Kinetics of icodextrin. Perit Dial Int. 1994; 14(Suppl 2):S45-50.
38. Abbott WE, Shea P. The treatment of temporary renal insufficiency (uremia) by peritoneal lavage. Am J Med Sci. 1946; 211:312-19.
39. Odel HM, Ferris DO, Power MH. Peritoneal lavage as an effective means of external excretion. Am J Med. 1950; 9:63-77.
40. Boen S. The evolution of peritoneal dialysis. In: Atkins RC, Thomson NM, Farrell PC, eds. Peritoneal Dialysis. Edinburgh: Churchill Livingstone; 1981:3-11.
41. Coles GA, Gokal R, Ogg C, Jani F, O'Donoghue DT, Cancarini GC, et al. A randomized controlled trial of a bicarbonate- and a bicarbonate/lactate-containing dialysis solution in CAPD. Perit Dial Int. 1997; 17:48-51.
42. Feriani M, Biasioli S, Borin D, Bragantini A, Brendolan S, Chiaramonte S, et al. Bicarbonate buffer for CAPD solutions. ASAIO Trans. 1985; 31:668-72.
43. Feriani M, Carobi C, LaGreca G, Buoncristiani U, Passlick-Deetjen J. Clinical experience with a 39 mmol/L bicarbonate buffered peritoneal dialysis solution. Perit Dial Int. 1997; 17:17-21.
44. Slingeneyer A, Faller B, Michel C, Przybylski C, Rolland R, Mion C. Increased ultrafiltration capacity using a new bicarbonate CAPD solution [Abstract]. Perit Dial Int. 1993; 13(Suppl 1):S57.
45. Yatzidis H. A new stable bicarbonate dialysis solution for peritoneal dialysis: Preliminary report. Perit Dial Int. 1991; 11:224-7.
46. Feriani M. Bicarbonate-buffered CAPD solutions: From clinical trials to clinical practice. Perit Dial Int. 1997; 17(Suppl 2):S51-5.
47. Schambye HT, Flesner P, Pedersen RB, Hardt-Madsen M, Chemnitz J, Christensen HK, et al. Bicarbonate-versus lactate-based CAPD fluids: A biocompatibility study in rabbits [Comments]. Perit Dial Int. 1992; 12:281-6.
48. Mackenzie RK, Holmes CJ, Moseley A, Jenkins JP, Williams JD, Coles GA, et al. Bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNFα secretion. J Am Soc Nephrol. 1998; 9:1499-506.
49. Mactier R, Sprosen T, Gokal R, Williams P, Lindbergh M, Naik R, et al. Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int. 1998; 53:1061-7.
50. 3-solution with low Na concentration over classical lactate-solutions for acute peritoneal dialysis in children [Abstract]. Pediatr Nephrol. 1997; 11:C77.
51. Schmitt C, Doetachmann R, Greiner C, Kirchgessner J, Mehis O, Schaefer F. Acid-base and solute transport kinetics using bicarbonate-vs. lactate-buffered PD fluids in children [Abstract]. Pediatr Nephrol. 1998; 12:C208.
52. Hutchison A, Gokal R. Peritoneal dialysis fluids for the future: Do we have the solution? Dialysis & Transplantation. 1992; 21:57-63.
53. Balfe J, Qamar I. The use of alternative peritoneal dialysis solutions in pediatric patients. Perit Dial Int. 1993; 13(Suppl 2):S95-100.